Jeffrey S. Farrow, See Remarks at Tarsus Pharmaceuticals, Inc. (TARS), sold 27,216 shares at $40.42 ($1.1M) on 2025-06-17, disclosed to the SEC on 2025-06-18.
Open-market sale of $1.1M TARS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.42 | 13,608 | $550K | 50.0% |
| 2 | $40.42 | 13,608 | $550K | 50.0% |
| Total | $40.42 avg | 27,216 | $1.1M | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $357K | — | Filing → |
| TARS | SELL | 2024-06-20 | $574K | — | Filing → |
| GBT | SELL | 2022-09-06 | $2.1M | — | Filing → |